Neurological disorders and neuro oncology impose a growing clinical and societal burden, while therapeutic development remains slow, costly, and uncertain.

Why do so many promising drugs fail? This article explores how spatial multiomics reveals hidden cell interactions, helping ...

Integrated Systems Biology and Genomics have fundamentally changed how cancer research progresses. Cancer is a disease of dysregulated systems — tumors ...

People communicate with each other, sometimes face to face, sometimes with a text message or phone call. Cells also ...

In this edition of the biotech bi-weekly, catch up on five innovative product launches – from lab balances to spatial solutions – and recent partnerships driving human health forward. Illumina (CA, ...

Abstract: Spatial transcriptomics enables the study of gene expression within the spatial context of tissues, offering valuable insights into tissue organization and function. However, technical ...

By analyzing brain tissue at single-cell resolution, researchers identified biological pathways that separate Alzheimer’s ...

A new study has uncovered how antidepressants affect different groups of serotonin-producing brain cells in opposite ways, ...

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of ...

A new study discovers a critical microglial cell transition that determines whether Alzheimer’s pathology causes dementia.

Muna Therapeutics, a clinical-stage biotechnology company pioneering a new era of drug discovery for neurodegenerative ...